264 related articles for article (PubMed ID: 8615057)
21. Lipoprotein composition and oxidative modification during therapy with gemfibrozil and lovastatin in patients with combined hyperlipidaemia.
Vázquez M; Zambón D; Hernández Y; Adzet T; Merlos M; Ros E; Laguna JC
Br J Clin Pharmacol; 1998 Mar; 45(3):265-9. PubMed ID: 9517370
[TBL] [Abstract][Full Text] [Related]
22. Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins.
Nakandakare E; Garcia RC; Rocha JC; Sperotto G; Oliveira HC; Quintão EC
Atherosclerosis; 1990 Dec; 85(2-3):211-7. PubMed ID: 2102085
[TBL] [Abstract][Full Text] [Related]
23. The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study.
Leaf DA; Connor WE; Illingworth DR; Bacon SP; Sexton G
JAMA; 1989 Dec; 262(22):3154-60. PubMed ID: 2681858
[TBL] [Abstract][Full Text] [Related]
24. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
Guyton JR; Blazing MA; Hagar J; Kashyap ML; Knopp RH; McKenney JM; Nash DT; Nash SD
Arch Intern Med; 2000 Apr; 160(8):1177-84. PubMed ID: 10789612
[TBL] [Abstract][Full Text] [Related]
25. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Nikkilä EA; Ylikahri R; Huttunen JK
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
[TBL] [Abstract][Full Text] [Related]
26. A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients.
Hanes DS; Nicholson PG; Raval DD; Hooper FL; Behrens MT; Weir MR
Am J Ther; 1997; 4(2-3):85-91. PubMed ID: 10423597
[TBL] [Abstract][Full Text] [Related]
27. The effect of gemfibrozil on lipid profile and glucose metabolism in hypertriglyceridaemic well-controlled non-insulin-dependent diabetic patients. For the Gemfibrozil Study Group.
Avogaro A; Piliego T; Catapano A; Miola M; Tiengo A
Acta Diabetol; 1999 Jun; 36(1-2):27-33. PubMed ID: 10436249
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.
Nestel P; Simons L; Barter P; Clifton P; Colquhoun D; Hamilton-Craig I; Sikaris K; Sullivan D
Atherosclerosis; 1997 Mar; 129(2):231-9. PubMed ID: 9105566
[TBL] [Abstract][Full Text] [Related]
29. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.
Knipscheer HC; Nurmohamed MT; Van den Ende A; Plaat B; Pruijs HJ; Mulder WJ; Kastelein JJ
J Intern Med; 1994 Oct; 236(4):377-84. PubMed ID: 7931040
[TBL] [Abstract][Full Text] [Related]
30. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
[TBL] [Abstract][Full Text] [Related]
31. Effect of gemfibrozil on composition of lipoproteins and distribution of LDL subspecies.
Tsai MY; Yuan J; Hunninghake DB
Atherosclerosis; 1992 Jul; 95(1):35-42. PubMed ID: 1642690
[TBL] [Abstract][Full Text] [Related]
32. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.
Syvänne M; Nieminen MS; Frick MH; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Ehnholm C; Taskinen MR
Circulation; 1998 Nov; 98(19):1993-9. PubMed ID: 9808595
[TBL] [Abstract][Full Text] [Related]
33. Gemfibrozil-induced decrease in serum ubiquinone and alpha- and gamma-tocopherol levels in men with combined hyperlipidaemia.
Aberg F; Appelkvist EL; Bröijersén A; Eriksson M; Angelin B; Hjemdahl P; Dallner G
Eur J Clin Invest; 1998 Mar; 28(3):235-42. PubMed ID: 9568470
[TBL] [Abstract][Full Text] [Related]
34. [Gemfibrozil in the treatment of lipid metabolism disorders].
Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV
Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321
[TBL] [Abstract][Full Text] [Related]
35. Combination of gemfibrozil and orlistat for treatment of combined hyperlipidemia with predominant hypertriglyceridemia.
Tolentino MC; Ferenczi A; Ronen L; Poretsky L
Endocr Pract; 2002; 8(3):208-12. PubMed ID: 12113634
[TBL] [Abstract][Full Text] [Related]
36. Long-term safety of pravastatin-gemfibrozil therapy in mixed hyperlipidemia.
Iliadis EA; Rosenson RS
Clin Cardiol; 1999 Jan; 22(1):25-8. PubMed ID: 9929751
[TBL] [Abstract][Full Text] [Related]
37. Comparison in patients with type 2 diabetes of fibric acid versus hepatic hydroxymethyl glutaryl-coenzyme a reductase inhibitor treatment of combined dyslipidemia.
McLaughlin T; Abbasi F; Lamendola C; Leary E; Reaven GM
Metabolism; 2002 Oct; 51(10):1355-9. PubMed ID: 12370858
[TBL] [Abstract][Full Text] [Related]
38. Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis.
Schiel R; Bambauer R; Müller UA
Int J Artif Organs; 1995 Dec; 18(12):786-93. PubMed ID: 8964646
[TBL] [Abstract][Full Text] [Related]
39. [Gemfibrozil in the treatment of hyperlipidemia].
Wang JJ; Song YM; Wang YS; Lin WH
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):131-4. PubMed ID: 2766068
[TBL] [Abstract][Full Text] [Related]
40. Effectiveness of statin-gemfibrozil combination therapy in patients with mixed hyperlipidemia: experience of a community lipid clinic and safety review from the literature.
Shammas NW; Kapalis MJ; Deckert J; Harris M; Dippel EJ; Labroo A; McKinney D
Prev Cardiol; 2003; 6(4):189-94. PubMed ID: 14605512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
